Aprea Therapeutics, Inc. financial statements
Aprea Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 285.76K | EODHD |
| Net income | −USD 12.6M | 10-K |
| Cash and equivalents | USD 14.6M | 10-Q |
Aprea Therapeutics, Inc. financials on 6ix · Aprea Therapeutics, Inc. on 6ix